With effect from 05 November 2020
Aurobindo Pharma has appointed Girish Paman Vanvari (DIN 07376482) as an Additional Director (Non-Executive and Independent) of the Company for a period of two years with effect from 5 November 2020, subject to the approval of the shareholders of the Company in the ensuing Annual General Meeting.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
